"The University of Kansas Cancer Center offers cancer treatment in Overland Park, Kansas. Patients have even greater access to treatment options and clinical trials available only at a National Cancer Institute-designated cancer center."

During the past decade, University of Kansas Cancer Center-Overland Park conducted 153 clinical trials. In the 10-year time frame, 153 clinical trials started and 55 clinical trials were completed, i.e. on average, 35.9% percent of trials that started reached the finish line to date. In the past 5 years, 66 clinical trials started and 42 clinical trials were completed. i.e. 63.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Kansas Cancer Center-Overland Park" #1 sponsor was "National Cancer Institute (NCI)" with 83 trials, followed by "SWOG Cancer Research Network" with 30 trials sponsored, "NRG Oncology" with 21 trials sponsored, "Alliance for Clinical Trials in Oncology" with 13 trials sponsored and "University of Kansas Medical Center" with 13 trials sponsored. Other sponsors include 36 different institutions and companies that sponsored additional 33 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Kansas Cancer Center-Overland Park" #1 collaborator was "National Cancer Institute (NCI)" with 73 trials as a collaborator, "NRG Oncology" with 17 trials as a collaborator, "Canadian Cancer Trials Group" with 8 trials as a collaborator, "Radiation Therapy Oncology Group" with 4 trials as a collaborator and "Bristol-Myers Squibb" with 3 trials as a collaborator. Other collaborators include 32 different institutions and companies that were collaborators in the rest 35 trials.

According to Clinical.Site data, the most researched conditions in "University of Kansas Cancer Center-Overland Park" are "Breast Cancer" (12 trials), "Recurrent Squamous Cell Lung Carcinoma" (8 trials), "Stage IV Lung Cancer AJCC v8" (7 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (7 trials) and "Invasive Breast Carcinoma" (6 trials). Many other conditions were trialed in "University of Kansas Cancer Center-Overland Park" in a lesser frequency.

Most popular intervention types in "University of Kansas Cancer Center-Overland Park" are "Drug" (155 trials), "Other" (91 trials), "Biological" (66 trials), "Radiation" (58 trials) and "Procedure" (52 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (44 trials), "Quality-of-Life Assessment" (41 trials), "Biospecimen Collection" (31 trials), "Computed Tomography" (29 trials) and "Questionnaire Administration" (25 trials). Other intervention names were less common.

The vast majority of trials in "University of Kansas Cancer Center-Overland Park" are 158 trials for "All" genders, 22 trials for "Female" genders and 17 trials for "Male" genders.

Currently, there are NaN active trials in "University of Kansas Cancer Center-Overland Park". undefined are not yet recruiting, 60 are recruiting, 89 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 36 completed trials in University of Kansas Cancer Center-Overland Park, 7 suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in University of Kansas Cancer Center-Overland Park, 26 "Phase 1" clinical trials were conducted, 111 "Phase 2" clinical trials and 90 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".